To identify newer potential therapeutic targets for MM, this study aimed to assess the expression of the UBE2T protein by immunohistochemical (IHC) staining of bone marrow biopsy specimens and also collected clinical data for a correlation analysis. This evidence concerns the gene UBE2T and Miyoshi myopathy.